Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer

Purpose: The cytochrome P-450 (CYP) and glutathione S -transferase (GST) enzyme systems may influence the biological effects of carcinogens, including estrogens. As such, these enzymes may predict the developmental risk of breast cancer, as well as be potential targets for chemoprevention. The purpo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2003-05, Vol.9 (5), p.1705-1709
Hauptverfasser: EL-RAYES, Basil F, ALI, Shadan, HEILBRUN, Lance K, LABABIDI, Samir, BOUWMAN, David, VISSCHER, David, PHILIP, Philip A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1709
container_issue 5
container_start_page 1705
container_title Clinical cancer research
container_volume 9
creator EL-RAYES, Basil F
ALI, Shadan
HEILBRUN, Lance K
LABABIDI, Samir
BOUWMAN, David
VISSCHER, David
PHILIP, Philip A
description Purpose: The cytochrome P-450 (CYP) and glutathione S -transferase (GST) enzyme systems may influence the biological effects of carcinogens, including estrogens. As such, these enzymes may predict the developmental risk of breast cancer, as well as be potential targets for chemoprevention. The purpose of this study was to compare the expression of GST-Pi and CYPs 1A1, 2B6, 2E1, and 3A4 in paired samples of normal and malignant breast tissue from patients with breast cancer and women undergoing reduction mammoplasty. Experimental design: Expression of CYPs 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified in breast tissue from 33 patients with breast cancer and in 17 women without history of cancer who underwent reduction mammoplasty. The expression of CYP 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified by immunoblotting. Results: CYP 1A1, 2E1, and 3A4 expression was significantly lower ( P < 0.05) in malignant tissue as compared with morphologically normal adjacent tissue. Conversely, GST-Pi expression was marginally lower in the normal tissue ( P = 0.08). No significant difference in enzyme expression was seen between the tissue from reduction mammoplasty and normal tissue from breast cancer patients. There was a trend for higher expression of CYP 2B6 and GST-Pi in the estrogen receptor expressing tumors than those tumors without expression ( P > 0.28). Conclusion: The expression of these enzymes was similar in morphologically normal breast tissue from patients with or without breast cancer. The expression of CYPs was down-regulated in the tumor tissue. The clinical significance of CYP alterations in breast cancer will need further characterization.
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_12738724</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12738724</sourcerecordid><originalsourceid>FETCH-LOGICAL-h269t-480fe8bebf66e02d9eb398662dc9abbd1ae45737f6d985689467a11914e8b8613</originalsourceid><addsrcrecordid>eNpFj0tLw0AUhQdRbK3-BZmNuArM-7HUUFuhoou6DjfJjYk0aZlJ0f57B1txdQ-X7xz4zsiUa20zKYw-T5lZlzElxYRcxfjJGFecqUsy4cJKZ4Wakpf8MG6rNmx7pG9KMwpDTReb_Qhj220HpOsAQ2wwQEQ6_94FjDH9aTfQ5b6HgT4GhDjSHIYKwzW5aGAT8eZ0Z-T9ab7Ol9nqdfGcP6yyVhg_ZsqxBl2JZWMMMlF7LKV3xoi68lCWNQdU2krbmNo7bZxXxgLnnqvUcobLGbk97u72ZY91sQtdD-FQ_Hkl4O4EQKxg0ySJqov_nLJeeiYSd3_k2u6j_eoCFtWvSNJECFVb-EIX3DItfwD0oWR8</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>EL-RAYES, Basil F ; ALI, Shadan ; HEILBRUN, Lance K ; LABABIDI, Samir ; BOUWMAN, David ; VISSCHER, David ; PHILIP, Philip A</creator><creatorcontrib>EL-RAYES, Basil F ; ALI, Shadan ; HEILBRUN, Lance K ; LABABIDI, Samir ; BOUWMAN, David ; VISSCHER, David ; PHILIP, Philip A</creatorcontrib><description>Purpose: The cytochrome P-450 (CYP) and glutathione S -transferase (GST) enzyme systems may influence the biological effects of carcinogens, including estrogens. As such, these enzymes may predict the developmental risk of breast cancer, as well as be potential targets for chemoprevention. The purpose of this study was to compare the expression of GST-Pi and CYPs 1A1, 2B6, 2E1, and 3A4 in paired samples of normal and malignant breast tissue from patients with breast cancer and women undergoing reduction mammoplasty. Experimental design: Expression of CYPs 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified in breast tissue from 33 patients with breast cancer and in 17 women without history of cancer who underwent reduction mammoplasty. The expression of CYP 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified by immunoblotting. Results: CYP 1A1, 2E1, and 3A4 expression was significantly lower ( P &lt; 0.05) in malignant tissue as compared with morphologically normal adjacent tissue. Conversely, GST-Pi expression was marginally lower in the normal tissue ( P = 0.08). No significant difference in enzyme expression was seen between the tissue from reduction mammoplasty and normal tissue from breast cancer patients. There was a trend for higher expression of CYP 2B6 and GST-Pi in the estrogen receptor expressing tumors than those tumors without expression ( P &gt; 0.28). Conclusion: The expression of these enzymes was similar in morphologically normal breast tissue from patients with or without breast cancer. The expression of CYPs was down-regulated in the tumor tissue. The clinical significance of CYP alterations in breast cancer will need further characterization.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>PMID: 12738724</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Aryl Hydrocarbon Hydroxylases - metabolism ; Biological and medical sciences ; Blotting, Western ; Breast - metabolism ; Breast Neoplasms - enzymology ; Cytochrome P-450 CYP1A1 - metabolism ; Cytochrome P-450 CYP2B6 ; Cytochrome P-450 CYP2E1 - metabolism ; Cytochrome P-450 CYP3A ; Cytochrome P-450 Enzyme System - metabolism ; Female ; Gene Expression Regulation, Enzymologic ; Glutathione S-Transferase pi ; Glutathione Transferase - metabolism ; Gynecology. Andrology. Obstetrics ; Humans ; Immunoenzyme Techniques ; Isoenzymes - metabolism ; Mammaplasty ; Mammary gland diseases ; Medical sciences ; Oxidoreductases, N-Demethylating - metabolism ; Receptors, Estrogen - metabolism ; Tumors</subject><ispartof>Clinical cancer research, 2003-05, Vol.9 (5), p.1705-1709</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14793902$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12738724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>EL-RAYES, Basil F</creatorcontrib><creatorcontrib>ALI, Shadan</creatorcontrib><creatorcontrib>HEILBRUN, Lance K</creatorcontrib><creatorcontrib>LABABIDI, Samir</creatorcontrib><creatorcontrib>BOUWMAN, David</creatorcontrib><creatorcontrib>VISSCHER, David</creatorcontrib><creatorcontrib>PHILIP, Philip A</creatorcontrib><title>Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>Purpose: The cytochrome P-450 (CYP) and glutathione S -transferase (GST) enzyme systems may influence the biological effects of carcinogens, including estrogens. As such, these enzymes may predict the developmental risk of breast cancer, as well as be potential targets for chemoprevention. The purpose of this study was to compare the expression of GST-Pi and CYPs 1A1, 2B6, 2E1, and 3A4 in paired samples of normal and malignant breast tissue from patients with breast cancer and women undergoing reduction mammoplasty. Experimental design: Expression of CYPs 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified in breast tissue from 33 patients with breast cancer and in 17 women without history of cancer who underwent reduction mammoplasty. The expression of CYP 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified by immunoblotting. Results: CYP 1A1, 2E1, and 3A4 expression was significantly lower ( P &lt; 0.05) in malignant tissue as compared with morphologically normal adjacent tissue. Conversely, GST-Pi expression was marginally lower in the normal tissue ( P = 0.08). No significant difference in enzyme expression was seen between the tissue from reduction mammoplasty and normal tissue from breast cancer patients. There was a trend for higher expression of CYP 2B6 and GST-Pi in the estrogen receptor expressing tumors than those tumors without expression ( P &gt; 0.28). Conclusion: The expression of these enzymes was similar in morphologically normal breast tissue from patients with or without breast cancer. The expression of CYPs was down-regulated in the tumor tissue. The clinical significance of CYP alterations in breast cancer will need further characterization.</description><subject>Aryl Hydrocarbon Hydroxylases - metabolism</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Breast - metabolism</subject><subject>Breast Neoplasms - enzymology</subject><subject>Cytochrome P-450 CYP1A1 - metabolism</subject><subject>Cytochrome P-450 CYP2B6</subject><subject>Cytochrome P-450 CYP2E1 - metabolism</subject><subject>Cytochrome P-450 CYP3A</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Female</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Glutathione S-Transferase pi</subject><subject>Glutathione Transferase - metabolism</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Isoenzymes - metabolism</subject><subject>Mammaplasty</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Oxidoreductases, N-Demethylating - metabolism</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Tumors</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFj0tLw0AUhQdRbK3-BZmNuArM-7HUUFuhoou6DjfJjYk0aZlJ0f57B1txdQ-X7xz4zsiUa20zKYw-T5lZlzElxYRcxfjJGFecqUsy4cJKZ4Wakpf8MG6rNmx7pG9KMwpDTReb_Qhj220HpOsAQ2wwQEQ6_94FjDH9aTfQ5b6HgT4GhDjSHIYKwzW5aGAT8eZ0Z-T9ab7Ol9nqdfGcP6yyVhg_ZsqxBl2JZWMMMlF7LKV3xoi68lCWNQdU2krbmNo7bZxXxgLnnqvUcobLGbk97u72ZY91sQtdD-FQ_Hkl4O4EQKxg0ySJqov_nLJeeiYSd3_k2u6j_eoCFtWvSNJECFVb-EIX3DItfwD0oWR8</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>EL-RAYES, Basil F</creator><creator>ALI, Shadan</creator><creator>HEILBRUN, Lance K</creator><creator>LABABIDI, Samir</creator><creator>BOUWMAN, David</creator><creator>VISSCHER, David</creator><creator>PHILIP, Philip A</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20030501</creationdate><title>Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer</title><author>EL-RAYES, Basil F ; ALI, Shadan ; HEILBRUN, Lance K ; LABABIDI, Samir ; BOUWMAN, David ; VISSCHER, David ; PHILIP, Philip A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h269t-480fe8bebf66e02d9eb398662dc9abbd1ae45737f6d985689467a11914e8b8613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aryl Hydrocarbon Hydroxylases - metabolism</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Breast - metabolism</topic><topic>Breast Neoplasms - enzymology</topic><topic>Cytochrome P-450 CYP1A1 - metabolism</topic><topic>Cytochrome P-450 CYP2B6</topic><topic>Cytochrome P-450 CYP2E1 - metabolism</topic><topic>Cytochrome P-450 CYP3A</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Female</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Glutathione S-Transferase pi</topic><topic>Glutathione Transferase - metabolism</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Isoenzymes - metabolism</topic><topic>Mammaplasty</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Oxidoreductases, N-Demethylating - metabolism</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>EL-RAYES, Basil F</creatorcontrib><creatorcontrib>ALI, Shadan</creatorcontrib><creatorcontrib>HEILBRUN, Lance K</creatorcontrib><creatorcontrib>LABABIDI, Samir</creatorcontrib><creatorcontrib>BOUWMAN, David</creatorcontrib><creatorcontrib>VISSCHER, David</creatorcontrib><creatorcontrib>PHILIP, Philip A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>EL-RAYES, Basil F</au><au>ALI, Shadan</au><au>HEILBRUN, Lance K</au><au>LABABIDI, Samir</au><au>BOUWMAN, David</au><au>VISSCHER, David</au><au>PHILIP, Philip A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>9</volume><issue>5</issue><spage>1705</spage><epage>1709</epage><pages>1705-1709</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>Purpose: The cytochrome P-450 (CYP) and glutathione S -transferase (GST) enzyme systems may influence the biological effects of carcinogens, including estrogens. As such, these enzymes may predict the developmental risk of breast cancer, as well as be potential targets for chemoprevention. The purpose of this study was to compare the expression of GST-Pi and CYPs 1A1, 2B6, 2E1, and 3A4 in paired samples of normal and malignant breast tissue from patients with breast cancer and women undergoing reduction mammoplasty. Experimental design: Expression of CYPs 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified in breast tissue from 33 patients with breast cancer and in 17 women without history of cancer who underwent reduction mammoplasty. The expression of CYP 1A1, 2B6, 2E1, 3A4, and GST-Pi was quantified by immunoblotting. Results: CYP 1A1, 2E1, and 3A4 expression was significantly lower ( P &lt; 0.05) in malignant tissue as compared with morphologically normal adjacent tissue. Conversely, GST-Pi expression was marginally lower in the normal tissue ( P = 0.08). No significant difference in enzyme expression was seen between the tissue from reduction mammoplasty and normal tissue from breast cancer patients. There was a trend for higher expression of CYP 2B6 and GST-Pi in the estrogen receptor expressing tumors than those tumors without expression ( P &gt; 0.28). Conclusion: The expression of these enzymes was similar in morphologically normal breast tissue from patients with or without breast cancer. The expression of CYPs was down-regulated in the tumor tissue. The clinical significance of CYP alterations in breast cancer will need further characterization.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>12738724</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2003-05, Vol.9 (5), p.1705-1709
issn 1078-0432
1557-3265
language eng
recordid cdi_pubmed_primary_12738724
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aryl Hydrocarbon Hydroxylases - metabolism
Biological and medical sciences
Blotting, Western
Breast - metabolism
Breast Neoplasms - enzymology
Cytochrome P-450 CYP1A1 - metabolism
Cytochrome P-450 CYP2B6
Cytochrome P-450 CYP2E1 - metabolism
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System - metabolism
Female
Gene Expression Regulation, Enzymologic
Glutathione S-Transferase pi
Glutathione Transferase - metabolism
Gynecology. Andrology. Obstetrics
Humans
Immunoenzyme Techniques
Isoenzymes - metabolism
Mammaplasty
Mammary gland diseases
Medical sciences
Oxidoreductases, N-Demethylating - metabolism
Receptors, Estrogen - metabolism
Tumors
title Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T09%3A28%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytochrome%20P450%20and%20Glutathione%20Transferase%20Expression%20in%20Human%20Breast%20Cancer&rft.jtitle=Clinical%20cancer%20research&rft.au=EL-RAYES,%20Basil%20F&rft.date=2003-05-01&rft.volume=9&rft.issue=5&rft.spage=1705&rft.epage=1709&rft.pages=1705-1709&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E12738724%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12738724&rfr_iscdi=true